354 related articles for article (PubMed ID: 7700520)
21. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
Mark KA; Soghomonian JJ; Yamamoto BK
J Neurosci; 2004 Dec; 24(50):11449-56. PubMed ID: 15601951
[TBL] [Abstract][Full Text] [Related]
22. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata.
Garcia M; Floran B; Arias-Montaño JA; Young JM; Aceves J
Neuroscience; 1997 Sep; 80(1):241-9. PubMed ID: 9252235
[TBL] [Abstract][Full Text] [Related]
23. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.
Zhang W; Yamada M; Gomeza J; Basile AS; Wess J
J Neurosci; 2002 Aug; 22(15):6347-52. PubMed ID: 12151512
[TBL] [Abstract][Full Text] [Related]
24. Sustained unilateral blockade of rat striatal M(1) muscarinic receptors with m1-toxin1 in vivo.
Liang J; Gutierrez-Ford C; Potter LT
Brain Res; 2001 Dec; 921(1-2):211-8. PubMed ID: 11720728
[TBL] [Abstract][Full Text] [Related]
25. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic regulation of the rat adrenal zona glomerulosa.
Jánossy A; Orsó E; Szalay KS; Jurányi Z; Beck M; Vizi ES; Vinson GP
J Endocrinol; 1998 May; 157(2):305-15. PubMed ID: 9659294
[TBL] [Abstract][Full Text] [Related]
27. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
Arbilla S; Kamal LA; Langer SZ
Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
[TBL] [Abstract][Full Text] [Related]
28. Release of gamma-[3H]aminobutyric acid from rat olfactory bulb and substantia nigra: differential modulation by glutamic acid.
Jaffé EH; Vaello ML
J Neurochem; 1989 Jun; 52(6):1766-74. PubMed ID: 2566648
[TBL] [Abstract][Full Text] [Related]
29. Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon.
Grillner P; Bonci A; Svensson TH; Bernardi G; Mercuri NB
Neuroscience; 1999; 91(2):557-65. PubMed ID: 10366013
[TBL] [Abstract][Full Text] [Related]
30. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
Brugnoli A; Pisanò CA; Morari M
Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
[TBL] [Abstract][Full Text] [Related]
31. Exocytotic release from neuronal cell bodies, dendrites and nerve terminals in sympathetic ganglia of the rat, and its differential regulation.
Zaidi ZF; Matthews MR
Neuroscience; 1997 Oct; 80(3):861-91. PubMed ID: 9276500
[TBL] [Abstract][Full Text] [Related]
32. Modulation by adenosine of both muscarinic M1-facilitation and M2-inhibition of [3H]-acetylcholine release from the rat motor nerve terminals.
Oliveira L; Timóteo MA; Correia-de-Sá P
Eur J Neurosci; 2002 Jun; 15(11):1728-36. PubMed ID: 12081652
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids inhibit striatonigral GABAergic neurotransmission in the mouse.
Wallmichrath I; Szabo B
Neuroscience; 2002; 113(3):671-82. PubMed ID: 12150787
[TBL] [Abstract][Full Text] [Related]
34. NMDA and carbachol but not AMPA affect differently the release of [3H]GABA in striosome- and matrix-enriched areas of the rat striatum.
Galli T; Artaud F; Torrens Y; Godeheu G; Desban M; Glowinski J; Chéramy A
Brain Res; 1994 Jun; 649(1-2):243-52. PubMed ID: 7525008
[TBL] [Abstract][Full Text] [Related]
35. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
[TBL] [Abstract][Full Text] [Related]
36. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release.
Kurokawa M; Kirk IP; Kirkpatrick KA; Kase H; Richardson PJ
Br J Pharmacol; 1994 Sep; 113(1):43-8. PubMed ID: 7812630
[TBL] [Abstract][Full Text] [Related]
38. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra.
Hatzipetros T; Yamamoto BK
Brain Res; 2006 Mar; 1076(1):60-7. PubMed ID: 16680828
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis.
Smolders I; Bogaert L; Ebinger G; Michotte Y
J Neurochem; 1997 May; 68(5):1942-8. PubMed ID: 9109520
[TBL] [Abstract][Full Text] [Related]
40. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
